1. Articles in category: Opioids

    25-48 of 281 « 1 2 3 4 5 ... 10 11 12 »
    1. Studies show economic distress true cause of opioid epidemic

      Studies show economic distress true cause of opioid epidemic

      As poor and working class Americans were being affected by losing major industries, therefore jobs, they were also incidentally being affected by the opioid crisis.

      Studies have found a correlation between growing unemployment and opioid abuse.

      A study published by JAMA found that counties with automotive assembly plants that closed, after 5 years had 85 percent higher rates of opioid-overdoses compared to counties where automotive assembly plants remained open.

      Read Full Article
    2. A recap of 2019's opioid litigation

      A recap of 2019's opioid litigation

      While there was much hope for a global resolution in 2019, experts say the talks simply resulted in confusion and frustration. 

      There were discussions of a global negotiation led by Judge Polster in Ohio's MDL while state attorneys pushed a separate deal. 

      Although the first bellwether trial in the MDL resulted in settlement, there is still no definitive admission, and attorney for plaintiffs Mark Lanier has stated that the counsel has not been able to test legal theories. 

      The lack of admission and ability to try issues has resulted in much frustration felt by victims families, as well as confusion of what is to come in 2020, may it be trial, settlement or otherwise. 

      Read Full Article
    3. What to expect from the opioid MDL in 2020

      What to expect from the opioid MDL in 2020

      While 2019 was a landmark year for litigation, 2020 could be an even bigger year. 

      The next bellwether trials are set to begin in mid-2020. 

      Judge Polster who presides over the litigation is also set to push for a settlement to resolve all the cases. Negotiations for a global settlement are also set to continue in 2020.

      If 2019 is any predictor, many more opioid defendants will reach settlements to avoid trial.

      Read Full Article
    4. Opioid litigation still big issue in 2020 for investors

      Opioid litigation still big issue in 2020 for investors

      The opioid epidemic has spun one of the most complex webs of litigation in American history.

      The litigation affected stock across the entire pharmaceutical supply chain, from manufacturers, distributors and retailers. 

      Stocks of opioid defendants took an impactful hit. Companies like Teva Pharmaceutical Industries shares were down 57% from January to the end of August. 

      Read Full Article
    5. Synthetic opioids could cause Asian opioid epidemic within a decade

      Synthetic opioids could cause Asian opioid epidemic within a decade

      Looking at the damage fentanyl has done to the U.S. in the last decade, it is likely Asia could receive similar treatment in the next. 

      It was only recently that it was confirmed that synthetic opioids such as fentanyl were contaminating the heroin supply in Asia in major cities.

      Experts say this should alarm authorities considering how deadly the synthetic opioid crisis has been in America. However, the experts explain that Asia is not as prepared to face the crisis.

      Read Full Article
    6. Study suggests that automobile plant closures linked to rise in opioid overdose deaths

      Study suggests that automobile plant closures linked to rise in opioid overdose deaths

      According to a recent study by the medical journal JAMA, an automobile plant closing in a county could contribute to 85% higher opioid overdose death rates among working-age adults after 5 years. 

      The study used a variable of counties where automobile plants did not close and there they found the difference in the overdose death rates. 

      The study illustrates that when economic opportunities disappear, people's economic wellbeing could adversely affect their health.

      Read Full Article
    7. FDA faces blame in opioid epidemic

      FDA faces blame in opioid epidemic

      A recently released report found that the Food and Drug Administration was plagued by a lack of training and oversight during the opioid crisis contributing to the epidemic that kills tens of thousands each year.

      The FDA may have failed to set strict enough standards and follow-through training for doctors about the risks associated with prescription opioids.

      A big problem was that the FDA let pharmaceutical companies develop the standards, and did not discourage aggressive marketing. 

       

      Read Full Article
    8. Top Product Liability Cases of 2019

      Top Product Liability Cases of 2019

      Top Product Liability Cases of 2019

      Opioid multidistrict litigation: National Prescription Opiate Litigation (MDL 2804)

      The national opioid litigation was initially transferred to Cleveland in 2017, and the first bellwether trial was planned to take place in October of 2019. The case was settled hours before the trial was set to begin. Judge Polster who presides over the case has set more bellwether tracks for a number of plaintiffs and defendants to occur within the next year. Some plaintiff attorneys are advocating for a global negotiation to settle the cases of all the entities within the MDL. 

      Oklahoma’s state opioid lawsuit:

      State of Oklahoma v. Purdue Pharma, et al.

      In Oklahoma’s state opioid litigation, Johnson and Johnson became ...

      Read Full Article
    9. Nevada given $333 million to fight opioid crisis

      Nevada given $333 million to fight opioid crisis

      The Department of Justice's Office of Justice Programs has awarded Nevada $333 billion to combat abuse and effectively respond to opioid-related overdoses.

      U.S. Attorney Nicholas A. Trutanich for the District of Nevada stated that they are thankful for the additional resources to address the opioid crisis within their communities.

      Grants will likely go toward emergency services, and other funds will likely be directed toward youth programs, research labs, and opioid-related research.

      Read Full Article
    10. Richard Sackler sought to downplay concerns of Oxycontin

      Richard Sackler sought to downplay concerns of Oxycontin

      Insights into Richard Sackler’s control of Purdue Pharma and his aggressive stance on marketing OxyContin were revealed last week after documents were unsealed revealing a 4-year court battle in Kentucky.

      The documents show that Sackler sought to quash any question about the potential for opioid abuse. 

      Email evidence shows that when personelle brought Oxycontin's addiction potential to the company's leadership, CEO Richard Sackler replied in an email chain that the concerns needed to be "obliterated".

      Picture: Getty

      Read Full Article
    11. Michigan sues opioid distributors as drug dealers

      Michigan sues opioid distributors as drug dealers

      Michigan Attorney General Dana Nessel filed a complaint Tuesday, against opioid drugmakers. 

      The state makes history as the first to sue opioid distributors as drug dealers.

      Nessel claims the companies knowingly and deliberately used their licenses to distribute drugs without controls, which was negligent and unlawful, therefore these actions subject the opioid distributors to liability under the Michigan Drug Dealers' Liability Act.

       Picture: AP

      Read Full Article
    12. New study suggests the U.S. is suffering from multiple opioid epidemics

      New study suggests the U.S. is suffering from multiple opioid epidemics

      A study by Iowa State University claims instead of one big epidemic, the United States is suffering from multiple simultaneous opioid epidemics.

      The study analyzed different counties from all across the country and found regional differences in the kind of opioids that cause the most overdose deaths, and considered that these differences should lead to policymakers considering varying strategies to address the epidemics.

      Because the opioid epidemics occur in different regions of the country, the study illustrates that there needs to be different policy responses for each of the different epidemics.

      Read Full Article
    13. Babies born with NAS cost the U.S. more than half a billion each year

      Babies born with NAS cost the U.S. more than half a billion each year

      The cost of babies born with neonatal abstinence syndrome (NAS), which is opioid withdrawal due to the mother's opioid intake, amounts to over $500 million each year and 4/5ths of this money comes from medicaid.

      Findings published Dec. 16 in the journal JAMA Pediatrics, explain that it is clear that state and federal governments ultimately bear this billion dollar burden.

      Dr. Stephen Patrick, director of Vanderbilt University's Center for Child Health Policy in Nashville, Tenn. believes that babies with NAS should be at the center of settlement discussions as they were a strong motivating factor for the opioid litigation. 

      Read Full Article
    14. Purdue's Sackler family got $11 billion payout amid bankruptcy

      Purdue's Sackler family got $11 billion payout amid bankruptcy

      A Purdue Pharma commissioned audit introduced in Monday's bankruptcy court proceedings outlined that the family has withdrawn $12.2 billion since 2008. Approximately $10.8 of these funds were withdrawn after several company executives pled guilty to promoting misleading marketing tactics to the public.

      The Purdue bankruptcy proceeding has been underway since September with around two dozen state attorney generals on board with the company's settlement proposal. 

      The Sackler family has offered $3 billion from their personal fortune to be used in the settlement agreement. 

      Read Full Article
    15. Home Depot Links Thefts to Opioid Crisis

      Home Depot Links Thefts to Opioid Crisis

      Home Depot Inc. executives said the nation’s opioid crisis could be contributing to an unexpected surge in thefts from its stores and warehouses.

      The company said distribution centers that house its goods and those of other retailers have been targets of organized groups of criminals who are stealing millions of dollars’ worth of products. The theft, which retailers call shrink, has gotten so bad that it will narrow Home Depot’s operating profit margins next year, it said on a call with analysts Wednesday.

      Home Depot’s admission is one of the first times a major U.S. retailer has specifically called out the opioid epidemic as a factor in its performance and financial results.

      In one instance, thieves ...

      Read Full Article
    16. Opioid manufacturers fighting to keep rap videos produced to promote opioids under wraps in opioid MDL

      Opioid manufacturers fighting to keep rap videos produced to promote opioids under wraps in opioid MDL

      It has been revealed that opioid manufacturers made parody videos in an effort to push opioids and prescribe more of the addictive, deadly painkillers.

      These music videos are being used as evidence in the MDL lawsuit in Cleveland, Ohio.

      The recently unsealed videos illustrate how opioid manufacturers produced music videos as aggressive marketing techniques even after they were warned against them, shortly after Purdue's 2007 penalty.

      The songs were made for sales conferences but were made public to show how much influence the rap songs had on worsening the outbreak of the opioid epidemic.

      Read Full Article
    17. Ohio AG Yost suggests new plan to utilize opioid settlement money

      Ohio AG Yost suggests new plan to utilize opioid settlement money

      Ohio Attorney General Dave Yost's office has proposed a plan for the opioid settlement funds to put a hypothetical guardrail around the funds to ensure they are used specifically for cause of the opioid epidemic.

      The plan would create the Ohio Recovery Foundation, a nonprofit to allocate funds to different resources around the state on a local level. The foundation would also invest funds to make sure those resources have funds in the future.

      The plan was conceived due to the fears that future lawmakers may divert the funds to resources not oriented toward recovery from the opioid epidemic. 

      Read Full Article
    18. The Supreme Court rejects Arizona's objective to sue Sackler family

      The Supreme Court rejects Arizona's objective to sue Sackler family

      The Supreme Court turned down a rare request from Arizona to bypass lower courts and argue their lawsuit against Purdue Pharma, L.P. before the justices themselves.

      Though five states filed a brief supporting Arizona, the Court refused the motion in a Monday order.

      The Arizona state lawsuit blames Purdue for using deceptive marketing schemes to sell painkillers, and contributing to the severity of the opioid crisis.

      Lawyers for Arizona bypassed the lower courts and filed their lawsuit with the Supreme Court, claiming the scope of the opioid epidemic and the wrongful actions of the Sackler family required prompt resolution.

       

      Read Full Article
    19. "Sell Baby Sell": unsealed documents uncover opioid marketing schemes

      "Sell Baby Sell": unsealed documents uncover opioid marketing schemes

      New details about marketing campaigns of opioid manufacturers have been revealed in the corporate documents and internal emails due to efforts of the Washington Post to unseal them.

      The unsealed reports reveal that in the decade leading up to Purdue's 2007 fine for misbranding Oxycontin, the company utilized a wide-ranging marketing campaign in attempts to convince the medical community that opioid addiction was rare. 

      The documents also explain other opioid manufacturers continued to market their products aggressively after the Purdue fine, after Purdue opened the door, increasing sales of oxycodone by 55%.

       

      Read Full Article
    20. The maker of OxyContin is spending over $1 million a week on lawyers while trying to go bankrupt

      The maker of OxyContin is spending over $1 million a week on lawyers while trying to go bankrupt

      The lawyers representing Purdue Pharma in its Chapter 11 bankruptcy proceedings have submitted their first two bills to the court and they show how expensive this multibillion-dollar restructuring will be: Nearly $8 million for seven weeks of work, with one partner billing almost a half-million dollars for the month of October alone.

      Read Full Article
    21. Schools poised to sue opioid drugmakers

      Schools poised to sue opioid drugmakers

      Many schools have seen effects from the opioid crisis, and some have decided to sue in federal court. 

      Miami-Dade County's School Board filed a federal lawsuit against dozens of opioid distributors and manufacturers.

      The lawsuit claims that the school was "forced to spend money trying to keep opioids out of schools and mitigating the addictive drugs’ harmful effects on students and families." 

      The school is the first in the country to sue and is a sign of more schools coming forward dealing with the aftershock of addiction in the school context.

      Read Full Article
    22. Small towns hit hardest by opioid crisis ditch MDL global negotiation

      Small towns hit hardest by opioid crisis ditch MDL global negotiation

      Small towns in regions hit hardest by the U.S. opioid epidemic have opted out of the MDL global negotiation in favor of filing their own lawsuits. 

      The 541 local governments that opted out included Florida’s Palm Beach County and counties in West Virginia which were some of the regions with the highest overdose death rates in the nation. 

      This has caused speculation that the regions believe the most timely route is filing their own suits to avoid a costly litigation.

      Read Full Article
    23. October 2020 trial date set for 2nd bellwether track in opioid MDL

      October 2020 trial date set for 2nd bellwether track in opioid MDL

      Judge Polster has set a trial date for October 2020 for the 2nd bellwether track in the opioid MDL. The cases included are Cabell county and the City of Huntington, West Virginia, and the cases are to be tried in West Virginia.

      Polster wants the West Virginia government to limit the type of defendants it will go to trial against to distributors and pharmacies.

      The parties are in disagreement on the geographic scope of discovery. The defendants said the scope should be limited to the plaintiff county jurisdiction, while plaintiffs asked the data be broadened to national, or at least include West Virginia, Ohio, Kentucky and Florida.

      Read Full Article
    25-48 of 281 « 1 2 3 4 5 ... 10 11 12 »
  1. Categories

    1. News.Law Categories:

      Big Law, Civil Plaintiff, Consumer Law, Coronavirus, Criminal Law, Drug Safety, Employment Safety, Opioids, Political and Legislative, Product safety, Securities, Special Topic, Trucking
    2. Targo:

      F-NRA, Gun Violence
  2. Popular Articles